Tamsulosin: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: In medicine, '''tamsulosin''' is a selective antagonist of alpha1-adrenergic receptors. ==External links== {{CZMed}}) |
Pat Palmer (talk | contribs) (WPAttribution) |
||
(3 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{subpages}} | |||
In [[medicine]], '''tamsulosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. | In [[medicine]], '''tamsulosin''' is a selective antagonist of alpha1-[[adrenergic receptor]]s. | ||
{{TOC|right}} | |||
==History== | |||
Flomax brand of tamsulosin was approved by the [[Food and Drug Administration]] in the [[United States of America|United States]] with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1997.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=020579 Drugs@FDA]. U S Food and Drug Administration</ref> A generic version was approved with a [http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2007.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=BasicSearch&Search_Button=Submit&searchTerm=077451 Drugs@FDA]. U S Food and Drug Administration</ref> | |||
== | ==Pharmacology== | ||
{{ | ===Administration=== | ||
===Distribution=== | |||
===Metabolism=== | |||
===Excretion=== | |||
===Toxicity=== | |||
==Attribution== | |||
{{WPAttribution}} | |||
==References== | |||
<references/> |
Latest revision as of 13:23, 1 July 2024
In medicine, tamsulosin is a selective antagonist of alpha1-adrenergic receptors.
History
Flomax brand of tamsulosin was approved by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 1997.[1] A generic version was approved with a Abbreviated New Drug Application (ANDA) in 2007.[2]
Pharmacology
Administration
Distribution
Metabolism
Excretion
Toxicity
Attribution
- Some content on this page may previously have appeared on Wikipedia.